Abstract
BackgroundCancer immunogenomics encompassing tumor cells and tumor microenvironment (TME) is critical for unravelling the complexity of tumor immunity, understanding the mechanism of action (MOA) for immunotherapies, and revealing potential predictive/pharmacodynamic...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have